Pfizer’s Vizimpro On Course For India But Competitive Arena Awaits
Executive Summary
Pfizer’s Vizimpro has been endorsed by an expert panel in India, paving the way for its potential introduction on the market, where other EGFR inhibitors including AstraZeneca’s Tagrisso have a head start.